GB202004462D0 - Antibody fragments - Google Patents

Antibody fragments

Info

Publication number
GB202004462D0
GB202004462D0 GBGB2004462.4A GB202004462A GB202004462D0 GB 202004462 D0 GB202004462 D0 GB 202004462D0 GB 202004462 A GB202004462 A GB 202004462A GB 202004462 D0 GB202004462 D0 GB 202004462D0
Authority
GB
United Kingdom
Prior art keywords
antibody fragments
fragments
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2004462.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Biopharma SRL
Original Assignee
UCB Biopharma SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCB Biopharma SRL filed Critical UCB Biopharma SRL
Priority to GBGB2004462.4A priority Critical patent/GB202004462D0/en
Publication of GB202004462D0 publication Critical patent/GB202004462D0/en
Priority to TW110111008A priority patent/TW202202520A/en
Priority to JP2022558096A priority patent/JP2023519576A/en
Priority to CN202180037575.9A priority patent/CN115667298A/en
Priority to US17/907,116 priority patent/US20240024520A1/en
Priority to MX2022012021A priority patent/MX2022012021A/en
Priority to ARP210100750A priority patent/AR121663A1/en
Priority to KR1020227037447A priority patent/KR20220160069A/en
Priority to BR112022019047A priority patent/BR112022019047A2/en
Priority to PCT/EP2021/057946 priority patent/WO2021191424A1/en
Priority to EP21715868.2A priority patent/EP4126936A1/en
Priority to IL296732A priority patent/IL296732A/en
Priority to CA3175034A priority patent/CA3175034A1/en
Priority to AU2021245031A priority patent/AU2021245031A1/en
Priority to CL2022002635A priority patent/CL2022002635A1/en
Priority to CONC2022/0015049A priority patent/CO2022015049A2/en
Ceased legal-status Critical Current

Links

GBGB2004462.4A 2020-03-27 2020-03-27 Antibody fragments Ceased GB202004462D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB2004462.4A GB202004462D0 (en) 2020-03-27 2020-03-27 Antibody fragments
AU2021245031A AU2021245031A1 (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
ARP210100750A AR121663A1 (en) 2020-03-27 2021-03-26 AUTONOMOUS KNOB DOMAIN PEPTIDES
BR112022019047A BR112022019047A2 (en) 2020-03-27 2021-03-26 AUTONOMOUS KNOB DOMAIN PEPTIDES
CN202180037575.9A CN115667298A (en) 2020-03-27 2021-03-26 Autonomous bulge domain peptides
US17/907,116 US20240024520A1 (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
MX2022012021A MX2022012021A (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides.
TW110111008A TW202202520A (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
KR1020227037447A KR20220160069A (en) 2020-03-27 2021-03-26 autonomous knob domain peptide
JP2022558096A JP2023519576A (en) 2020-03-27 2021-03-26 autonomous knob domain peptide
PCT/EP2021/057946 WO2021191424A1 (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
EP21715868.2A EP4126936A1 (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
IL296732A IL296732A (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
CA3175034A CA3175034A1 (en) 2020-03-27 2021-03-26 Autonomous knob domain peptides
CL2022002635A CL2022002635A1 (en) 2020-03-27 2022-09-27 Autonomous knob domain peptides
CONC2022/0015049A CO2022015049A2 (en) 2020-03-27 2022-10-21 Autonomous knob domain peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2004462.4A GB202004462D0 (en) 2020-03-27 2020-03-27 Antibody fragments

Publications (1)

Publication Number Publication Date
GB202004462D0 true GB202004462D0 (en) 2020-05-13

Family

ID=70553376

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2004462.4A Ceased GB202004462D0 (en) 2020-03-27 2020-03-27 Antibody fragments

Country Status (2)

Country Link
AR (1) AR121663A1 (en)
GB (1) GB202004462D0 (en)

Also Published As

Publication number Publication date
AR121663A1 (en) 2022-06-29

Similar Documents

Publication Publication Date Title
SI3872091T1 (en) Antibodies against sars-cov-2
IL286690A (en) Anti-egfrviii antibodies and antigen-binding fragments thereof
IL308741A (en) Anti-sirp-alpha antibodies
IL311043A (en) Anti-il-11rα antibodies
IL308100A (en) Antibodies
IL300142A (en) ANTI-IL13Ralpha2 ANTIBODIES
GB202015115D0 (en) ZIP12 Antibody
GB202105110D0 (en) Anti-CD73 antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB202008095D0 (en) Antibody fragments
GB202004462D0 (en) Antibody fragments
EP4342989A4 (en) Anti-norovirus antibody
EP4342909A4 (en) Anti-norovirus antibody
GB202106027D0 (en) Antibody
GB202105933D0 (en) Anti-IL1rap antibody
GB202014969D0 (en) ZIP12 antibody
GB201911931D0 (en) Anti-C7 antibody or antibody fragment
IL310245A (en) Anti-hla-g antibodies
GB202208773D0 (en) Anti-SARS2-S antibodies
IL308782A (en) Antibodies
IL307175A (en) Il-38-specific antibodies
GB202116709D0 (en) Antibodies
GB202115824D0 (en) Antibodies
GB202112297D0 (en) Antibodies
IL299767A (en) Anti-αlpha-4-βeta-7 antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)